chr14-105051004-T-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_013345.4(GPR132):c.1133A>T(p.Glu378Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000343 in 1,459,230 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_013345.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GPR132 | NM_013345.4 | c.1133A>T | p.Glu378Val | missense_variant | 4/4 | ENST00000329797.8 | |
LOC124903398 | XR_007064368.1 | n.335-4405T>A | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GPR132 | ENST00000329797.8 | c.1133A>T | p.Glu378Val | missense_variant | 4/4 | 1 | NM_013345.4 | A2 | |
GPR132 | ENST00000392585.2 | c.1106A>T | p.Glu369Val | missense_variant | 3/3 | 1 | P2 | ||
GPR132 | ENST00000551869.1 | c.*1159A>T | 3_prime_UTR_variant, NMD_transcript_variant | 3/3 | 1 | ||||
GPR132 | ENST00000539291.6 | c.1133A>T | p.Glu378Val | missense_variant | 5/5 | 2 | A2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000343 AC: 5AN: 1459230Hom.: 0 Cov.: 32 AF XY: 0.00000551 AC XY: 4AN XY: 725340
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 25, 2023 | The c.1133A>T (p.E378V) alteration is located in exon 4 (coding exon 2) of the GPR132 gene. This alteration results from a A to T substitution at nucleotide position 1133, causing the glutamic acid (E) at amino acid position 378 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.